Comments
Loading...
Bilibili Analyst Ratings and Price Targets | NASDAQ:BILI | Benzinga
Bilibili Inc has a consensus price target of $26.84 based on the ratings of 16 analysts. The high is $120 issued by Baird on August 18, 2023. The low is $12.5 issued by Citigroup on March 11, 2024. The 3 most-recent analyst ratings were released by Benchmark, Barclays, and Barclays on February 21, 2025, February 21, 2025, and November 18, 2024, respectively. With an average price target of $26.33 between Benchmark, Barclays, and Barclays, there's an implied 49.62% upside for Bilibili Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Benchmark
Barclays
Mizuho
B of A Securities
Bernstein
1calculated from analyst ratings
Analyst Ratings for Bilibili
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/21/2025 | Buy Now | 70.45% | Benchmark | Fawne Jiang67% | $24 → $30 | Maintains | Buy | Get Alert |
| 02/21/2025 | Buy Now | 42.04% | Barclays | Jiong Shao66% | $24 → $25 | Maintains | Overweight | Get Alert |
| 11/18/2024 | Buy Now | 36.36% | Barclays | Jiong Shao66% | $19 → $24 | Maintains | Overweight | Get Alert |
| 11/15/2024 | Buy Now | 36.36% | Benchmark | Fawne Jiang67% | $16 → $24 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | 19.32% | Mizuho | James Lee78% | $17 → $21 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 27.84% | B of A Securities | Brad Sills69% | $19 → $22.5 | Maintains | Buy | Get Alert |
| 09/03/2024 | Buy Now | 7.95% | B of A Securities | Brad Sills69% | $18 → $19 | Maintains | Buy | Get Alert |
| 08/23/2024 | Buy Now | -26.14% | Bernstein | Robin Zhu33% | $12 → $13 | Maintains | Market Perform | Get Alert |
| 08/23/2024 | Buy Now | 7.95% | Barclays | Jiong Shao66% | $14 → $19 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 08/22/2024 | Buy Now | 2.27% | Nomura | Jialong Shi75% | → $18 | Upgrade | Neutral → Buy | Get Alert |
| 06/18/2024 | Buy Now | 19.32% | JP Morgan | Daniel Chen39% | → $21 | Upgrade | Neutral → Overweight | Get Alert |
| 05/31/2024 | Buy Now | 2.27% | UBS | Felix Liu45% | $11.9 → $18 | Upgrade | Neutral → Buy | Get Alert |
| 05/24/2024 | Buy Now | -9.09% | Benchmark | Fawne Jiang67% | $15 → $16 | Maintains | Buy | Get Alert |
| 05/24/2024 | Buy Now | -20.46% | Barclays | Jiong Shao66% | $10 → $14 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | -4.55% | CLSA | Elinor Leung33% | $12.2 → $16.8 | Upgrade | Outperform → Buy | Get Alert |
| 05/10/2024 | Buy Now | -3.41% | Mizuho | James Lee78% | $15 → $17 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | -28.98% | Citigroup | Brian Gong65% | $18 → $12.5 | Downgrade | Buy → Neutral | Get Alert |
| 03/11/2024 | Buy Now | -37.5% | JP Morgan | Daniel Chen39% | $10 → $11 | Upgrade | Underweight → Neutral | Get Alert |
| 03/08/2024 | Buy Now | -14.77% | Benchmark | Fawne Jiang67% | $21 → $15 | Maintains | Buy | Get Alert |
| 03/08/2024 | Buy Now | -14.77% | Mizuho | James Lee78% | $16 → $15 | Maintains | Buy | Get Alert |
| 01/17/2024 | Buy Now | -9.09% | Mizuho | James Lee78% | $18 → $16 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | -25% | UBS | Felix Liu45% | $22 → $13.2 | Downgrade | Buy → Neutral | Get Alert |
| 11/30/2023 | Buy Now | 19.32% | Benchmark | Fawne Jiang67% | $35 → $21 | Maintains | Buy | Get Alert |
| 11/30/2023 | Buy Now | -11.36% | Goldman Sachs | Lincoln Kong22% | $17.4 → $15.6 | Maintains | Neutral | Get Alert |
| 11/30/2023 | Buy Now | -43.18% | Barclays | Jiong Shao66% | $15 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/12/2023 | Buy Now | -1.14% | Goldman Sachs | Lincoln Kong22% | $19.6 → $17.4 | Maintains | Neutral | Get Alert |
| 08/21/2023 | Buy Now | -14.77% | Barclays | Jiong Shao66% | $16 → $15 | Maintains | Equal-Weight | Get Alert |
| 08/18/2023 | Buy Now | 25% | UBS | Felix Liu45% | $23 → $22 | Maintains | Buy | Get Alert |
| 08/18/2023 | Buy Now | 98.86% | Benchmark | Jason English55% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 08/18/2023 | Buy Now | 581.81% | Baird | David Koning76% | $140 → $120 | Maintains | Neutral | Get Alert |
| 07/27/2023 | Buy Now | -26.14% | JP Morgan | Daniel Chen39% | → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/25/2023 | Buy Now | -9.09% | HSBC | Charlotte Wei6% | $17 → $16 | Maintains | Hold | Get Alert |
| 06/08/2023 | Buy Now | 30.68% | UBS | Felix Liu45% | $35 → $23 | Maintains | Buy | Get Alert |
| 06/05/2023 | Buy Now | 98.86% | Benchmark | Jason English55% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 98.86% | Benchmark | Jason English55% | → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 42.04% | B of A Securities | Brad Sills69% | $28 → $25 | Maintains | Buy | Get Alert |
| 06/02/2023 | Buy Now | 36.36% | Citigroup | Brian Gong65% | $28 → $24 | Maintains | Buy | Get Alert |
| 06/02/2023 | Buy Now | -3.41% | HSBC | Charlotte Wei6% | $22 → $17 | Maintains | Hold | Get Alert |
| 03/03/2023 | Buy Now | 98.86% | Benchmark | Jason English55% | → $35 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | 59.09% | Citigroup | Brian Gong65% | → $28 | Upgrade | Neutral → Buy | Get Alert |
| 01/09/2023 | Buy Now | 43.75% | Goldman Sachs | Lincoln Kong22% | $22.2 → $25.3 | Maintains | Neutral | Get Alert |
| 11/30/2022 | Buy Now | 26.13% | Goldman Sachs | Lincoln Kong22% | $25.6 → $22.2 | Maintains | Neutral | Get Alert |
| 11/30/2022 | Buy Now | -9.09% | Barclays | Jiong Shao66% | $13 → $16 | Maintains | Equal-Weight | Get Alert |
| 11/03/2022 | Buy Now | -34.66% | B of A Securities | Brad Sills69% | $42 → $11.5 | Downgrade | Buy → Neutral | Get Alert |
| 10/28/2022 | Buy Now | -26.14% | Barclays | Jiong Shao66% | $21 → $13 | Maintains | Equal-Weight | Get Alert |
| 10/27/2022 | Buy Now | -31.82% | Citigroup | Brian Gong65% | $38 → $12 | Downgrade | Buy → Neutral | Get Alert |
| 10/25/2022 | Buy Now | 13.64% | JP Morgan | — | $30 → $20 | Maintains | Overweight | Get Alert |
| 09/09/2022 | Buy Now | 70.45% | Benchmark | Fawne Jiang67% | $56 → $30 | Maintains | Buy | Get Alert |
| 09/09/2022 | Buy Now | 70.45% | UBS | Felix Liu45% | $40 → $30 | Maintains | Buy | Get Alert |
| 09/09/2022 | Buy Now | 19.32% | Barclays | Jiong Shao66% | $26 → $21 | Maintains | Equal-Weight | Get Alert |
| 09/07/2022 | Buy Now | — | JP Morgan | Daniel Chen39% | — | Assumes | → Overweight | Get Alert |
| 06/13/2022 | Buy Now | 42.04% | JP Morgan | Alex Yao62% | $19 → $25 | Maintains | Neutral | Get Alert |
| 06/10/2022 | Buy Now | 155.68% | Citigroup | Brian Gong65% | $46 → $45 | Maintains | Buy | Get Alert |
| 06/10/2022 | Buy Now | 47.73% | Barclays | Jiong Shao66% | $24 → $26 | Maintains | Equal-Weight | Get Alert |
| 05/25/2022 | Buy Now | 43.75% | CLSA | Elinor Leung33% | $33.4 → $25.3 | Maintains | Outperform | Get Alert |
| 05/16/2022 | Buy Now | 7.95% | JP Morgan | Alex Yao62% | $15 → $19 | Upgrade | Underweight → Neutral | Get Alert |
| 05/03/2022 | Buy Now | 36.36% | Barclays | Jiong Shao66% | $32 → $24 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Bilibili (BILI) stock?
The latest price target for Bilibili (NASDAQ:BILI) was reported by Benchmark on February 21, 2025. The analyst firm set a price target for $30.00 expecting BILI to rise to within 12 months (a possible 70.45% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bilibili (BILI)?
The latest analyst rating for Bilibili (NASDAQ:BILI) was provided by Benchmark, and Bilibili maintained their buy rating.
When was the last upgrade for Bilibili (BILI)?
The last upgrade for Bilibili Inc happened on August 23, 2024 when Barclays raised their price target to $19. Barclays previously had an equal-weight for Bilibili Inc.
When was the last downgrade for Bilibili (BILI)?
The last downgrade for Bilibili Inc happened on March 11, 2024 when Citigroup changed their price target from $18 to $12.5 for Bilibili Inc.
When is the next analyst rating going to be posted or updated for Bilibili (BILI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bilibili, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bilibili was filed on February 21, 2025 so you should expect the next rating to be made available sometime around February 21, 2026.
Is the Analyst Rating Bilibili (BILI) correct?
While ratings are subjective and will change, the latest Bilibili (BILI) rating was a maintained with a price target of $24.00 to $30.00. The current price Bilibili (BILI) is trading at is $17.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
